NEW YORK (GenomeWeb News) – The US Federal Trade Commission today said that Thermo Fisher Scientific has agreed to sell certain assets to GE Healthcare as a condition of getting clearance for its acquisition of Life Technologies.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: global genetic diversity map, and more.
The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.
In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."
Stat News reports that there's muted opposition to the Kuwaiti DNA database law.